KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Shares Outstanding (Weighted Average) (2016 - 2025)

Pacific Biosciences Of California has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $300.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $300.0 million for Q4 2025, up 9.28% from a year ago — trailing twelve months through Dec 2025 was $300.0 million (up 9.28% YoY), and the annual figure for FY2025 was $300.0 million, up 9.28%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $300.0 million at Pacific Biosciences Of California, roughly flat from $299.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for PACB hit a ceiling of $300.0 million in Q4 2025 and a floor of $11.2 million in Q3 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $249.9 million (2023), compared with a mean of $239.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 93.28% in 2021 and later surged 1907.35% in 2022.
  • Pacific Biosciences Of California's Shares Outstanding (Weighted Average) stood at $204.1 million in 2021, then rose by 10.0% to $224.6 million in 2022, then increased by 12.95% to $253.6 million in 2023, then increased by 8.22% to $274.5 million in 2024, then grew by 9.28% to $300.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $300.0 million (Q4 2025), $299.3 million (Q3 2025), and $298.5 million (Q2 2025) per Business Quant data.